Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence

Breast Cancer Research : BCR
Daniele SantiniGiuseppe Tonini

Abstract

Bisphosphonates (BPs) are approved as standard therapy in breast cancer for the treatment of bone metastases, since they were demonstrated to reduce the prevalence of skeletal-related events including fractures and hypercalcemia. In the adjuvant setting, BPs can be given to prevent and treat tumor therapy-induced bone loss in premenopausal and postmenopausal women and, owing to their beneficial effect on bone turnover, have also been evaluated for prevention of bone metastases occurrence. In this article we will review the mechanisms through which BPs have been demonstrated to prevent premetastatic niche formation and cell proliferation in bone lesions. Moreover, preclinical evidence of antitumoral effects of BPs will be presented and results from the most important clinical trials will be described critically. BPs may clearly play a clinically important role in early breast cancer in a postmenopausal adjuvant setting.

References

Aug 1, 1996·The Journal of Clinical Investigation·G van der PluijmS Papapoulos
Nov 15, 1997·Cancer·R E Coleman
Apr 26, 2000·British Journal of Cancer·S G SenaratneK W Colston
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jeanette WoodJonathan R Green
Aug 27, 2005·The New England Journal of Medicine·Stephan BraunKlaus Pantel
May 3, 2006·Cancer Research·Linheng Li, William B Neaves
Dec 23, 2006·Cancer Metastasis Reviews·Rosandra N KaplanDavid Lyden
Jan 30, 2007·Breast Cancer Research and Treatment·Sven BeckerTanja Fehm
Feb 22, 2007·Journal of the National Cancer Institute·Florence DaubinéPhilippe Clézardin
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniele SantiniGiuseppe Tonini
Oct 5, 2007·Nature·Antoine E KarnoubRobert A Weinberg
Apr 22, 2008·Cancer Treatment Reviews·M C WinterR E Coleman
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark B MeadsWilliam S Dalton
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francois-Clément BidardUNKNOWN Institut Curie Breast Cancer Study Group
Jul 31, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I J DielF Schuetz
Feb 14, 2009·The New England Journal of Medicine·Michael GnantC Marth
Jul 24, 2010·Neoplasia : an International Journal for Oncology Research·Pierrick G FournierPhilippe Clézardin
Aug 21, 2010·Current Pharmaceutical Design·S P SyddallI Holen
Dec 22, 2010·Breast Cancer Research : BCR·Michael Gnant, Peyman Hadji
May 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M GalloN Normanno
May 20, 2011·Nature Reviews. Cancer·Katherine N WeilbaecherLaurie K McCauley
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allan LiptonMichael Pollak
Oct 15, 2011·The New England Journal of Medicine·Robert E ColemanUNKNOWN AZURE Investigators
Mar 3, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E-F SolomayerT Fehm
Jul 4, 2012·Journal of the National Cancer Institute·Robert ColemanPhilippe Clezardin
Oct 11, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanN Bundred
Dec 21, 2012·Journal of Internal Medicine·A Santamaria-Martínez, J Huelsken
Jan 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul E GossLois E Shepherd
Apr 2, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Penelope D OttewellIngunn Holen
Aug 7, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Andreas D HartkopfDiethelm Wallwiener
Nov 19, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M GnantUNKNOWN Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
Feb 1, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanN Bundred
Mar 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M GalloN Normanno
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E-F SolomayerT Fehm

❮ Previous
Next ❯

Citations

Feb 17, 2017·Advanced Healthcare Materials·Robin A NadarSander C G Leeuwenburgh
Feb 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tamer M SakrMaged E Mohamed
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Michael GnantLowell Schnipper
Apr 26, 2019·Mini Reviews in Medicinal Chemistry·Sonia TeixeiraJoão Costa-Rodrigues
Dec 26, 2018·Current Breast Cancer Reports·Arielle HeekeFilipa Lynce
Sep 30, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gad RennertHedy S Rennert
Sep 3, 2021·Journal of Pharmaceutical Sciences·Debyashreeta BarikMamoni Dash

❮ Previous
Next ❯

Software Mentioned

ZO
AZURE
Fast

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis